CoverageForm 410-K10-Q8-K13D13G13F

Cyclacel Pharmaceuticals, Inc.

CYCCCIK 0001130166 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewrite
Risk Factors:tone -0.0283Δ+0.000149% similar+155/-332
MD&A:tone -0.0046Δ+0.001961% similar+72/-59

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Cyclacel Pharmaceuticals, Inc.

NameRolesFilings
Yap Kim Choy
10% Owner
7
Kua Khai Loon
10% Owner
6
Fitters Diversified Berhad
10% Owner
5
Ong Yee Lung
10% Owner
5
Ferguson Kenneth M.
Director
3

Showing 1-5 of 19

Page 1 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Cyclacel Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Kua Khai Loon6100%+65.0%+73.0%+75.1%+31.9%
2Fitters Diversified Berhad5100%+62.1%+62.5%+74.3%+49.3%
3Ong Yee Lung3100%+44.7%+31.9%+77.9%+24.5%
4Yap Kim Choy6100%+30.5%+30.1%+37.0%+24.5%

All filings

54 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue